|Expense ratio (net)||1.45%|
|Morningstar risk rating||High|
|Last cap gain||0.00|
|Inception date||19 Jun 2000|
|Average for category||N/A|
The decline in biotech stocks is momentary and we expect the industry to bounce back in the coming days. So consider investing in these three biotech mutual funds.